Solid biosciences reports inducement grants under nasdaq listing rule 5635(c)(4)

Charlestown, mass., april 01, 2025 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 43,374 restricted stock units (“rsus”) to three newly hired employees.

SLDB Ratings Summary

SLDB Quant Ranking